EVAX ▲ +2.9% - Evaxion A/S
$EVAX - New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
06-NOV-2026 11:00 AM ET
Share this post
More filings for $EVAX
EVAX ▼ -2.3% - Evaxion A/SNov 4, 2026EVAX ▼ -1.4% - Evaxion A/SNov 3, 2026EVAX ▼ -2.2% - Evaxion A/SOct 23, 2026EVAX ▲ +15.7% - Evaxion A/SOct 19, 2026EVAX ▲ +4.1% - Evaxion A/SOct 2, 2026EVAX ▲ +1.9% - Evaxion A/SSep 14, 2026
View full $EVAX filing history →💬 Comments
Loading comments…
Leave a comment